GlassScriptPhysician profile
Abraham Knoll
NPI 1932143633
$1,876.26
in general payments reported to CMS, 2019-2025
32 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $286 · 2021: $404 · 2022: $195 · 2023: $234 · 2024: $217 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $651.25 | 2019-2025 | Rezum Generator, General - Erectile Dysfunction, Spaceoar System |
| 180 Medical, INC. | $150.66 | 2019-2025 | |
| Tolmar, INC. | $140.12 | 2023-2025 | Eligard, Jatenzo |
| Tolmar Pharmaceuticals, INC. | $100.59 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $96.76 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $68.21 | 2019-2023 | Myrbetriq |
| Immunitybio, INC. | $67.91 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $64.23 | 2019-2024 | Adstiladrin |
| Biocompatibles, INC. | $51.33 | 2019 | |
| Abbvie INC. | $39.69 | 2023 | |
| Coloplast Corp | $37.95 | 2019-2020 | |
| Medtronic USA, INC. | $36.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.21 | 2022-2023 | |
| Myriad Genetic Laboratories, INC. | $33.37 | 2021-2024 | Prolaris |
| Pfizer INC. | $31.43 | 2019-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $28.57 | 2021 | |
| Urovant Sciences INC | $26.43 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.43 | 2025 | Lynparza |
| Antares Pharma, INC. | $16.00 | 2023 | Tlando, Xyosted, Nocdurna |
| Progenics Pharmaceuticals, INC. | $15.87 | 2025 | |
| Dentsply Ih Ab | $15.52 | 2021 | |
| Laborie Medical Technologies Corp. | $15.18 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Verity Pharmaceuticals INC. | $14.78 | 2022 | |
| Procept Biorobotics Corporation | $14.63 | 2024 | Aquabeam System |
| Allergan, INC. | $14.54 | 2022 | |
| Duchesnay USA Incorporated | $14.48 | 2019 | |
| Janssen Biotech, INC. | $14.15 | 2023 | Erleada |
| Urogen Pharma, INC. | $13.92 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.77 | 2022 | |
| Dendreon Pharmaceuticals LLC | $11.84 | 2019 | |
| Blue Earth Diagnostics | $11.84 | 2019 | |
| Myovant Sciences INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Knoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.